Norry Elliot's Form 4 filing
Adaptimmune Therapeutics PLC (ADAPY) · filed Jan 15, 2025
- Accession no.
- 0001104659-25-003771
- Filed
- Jan 15, 2025
- Trade date
- Jan 13-15, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $12.9K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Norry ElliotCIK 0001798117 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 13, 2025 | American Depositary Shares representing Ordinary Shares | SSaleDisposed | −4,268 | $0.59 | −$2,518.12 | 5,845 | Direct | |
| Jan 13, 2025 | American Depositary Shares representing Ordinary Shares | SSaleDisposed | −8,124 | $0.59 | −$4,793.16 | 11,516 | Direct | |
| Jan 15, 2025 | American Depositary Shares representing Ordinary Shares | SSaleDisposed | −9,803 | $0.57 | −$5,587.71 | 13,756 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.